
Acubiosys is a biotechnology organization headquartered in Hyderabad, India, focused on a "science first" approach to drug discovery and development. They provide research solutions from early-stage ideas to Investigational New Drug (IND) filing, covering services like preclinical ADMET, animal efficacy studies, non-GLP TOX studies, novel drug delivery products, analytical support, and formulation development. They utilize AI-enabled approaches and ML models to identify drug-disease relationships and de-risk the drug discovery process. Acubiosys aims to bring treatments from prediction to patients by addressing unmet medical needs through innovative drug delivery systems and drug repurposing strategies.

Acubiosys is a biotechnology organization headquartered in Hyderabad, India, focused on a "science first" approach to drug discovery and development. They provide research solutions from early-stage ideas to Investigational New Drug (IND) filing, covering services like preclinical ADMET, animal efficacy studies, non-GLP TOX studies, novel drug delivery products, analytical support, and formulation development. They utilize AI-enabled approaches and ML models to identify drug-disease relationships and de-risk the drug discovery process. Acubiosys aims to bring treatments from prediction to patients by addressing unmet medical needs through innovative drug delivery systems and drug repurposing strategies.